The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma

被引：0

作者：

Furtado, Michelle ^{[1
]}

Clarke, Kathleen ^{[1
]}

Medd, Patrick ^{[1
]}

Hunter, Hannah ^{[1
]}

Rule, Simon ^{[1
]}

机构：

[1] Plymouth Hosp NHS Trust, Derriford Hosp, Plymouth PL6 8DH, Devon, England

来源：

LEUKEMIA & LYMPHOMA | 2016年 / 57卷 / 02期

关键词：

BRENTUXIMAB VEDOTIN; TARGETING BTK; IBRUTINIB;

D O I：

10.3109/10428194.2015.1050665

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：461 / 462

页数：2

共 13 条

[1] Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia [J].

Byrd, John C. ;

Furman, Richard R. ;

Coutre, Steven E. ;

Flinn, Ian W. ;

Burger, Jan A. ;

Blum, Kristie A. ;

Grant, Barbara ;

Sharman, Jeff P. ;

Coleman, Morton ;

Wierda, William G. ;

Jones, Jeffrey A. ;

Zhao, Weiqiang ;

Heerema, Nyla A. ;

Johnson, Amy J. ;

Sukbuntherng, Juthamas ;

Chang, Betty Y. ;

Clow, Fong ;

Hedrick, Eric ;

Buggy, Joseph J. ;

James, Danelle F. ;

O'Brien, Susan .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :32-42

[2] Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma [J].

Chen, Robert ;

Palmer, Joycelynne M. ;

Tsai, Ni-Chun ;

Thomas, Sandra H. ;

Siddiqi, Tanya ;

Popplewell, Leslie ;

Faro, Len ;

Nademanee, Auayporn ;

Forman, Stephen J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) :1864-1868

[3] Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma [J].

Chen, Robert ;

Palmer, Joycelynne M. ;

Thomas, Sandra H. ;

Tsai, Ni-Chun ;

Farol, Len ;

Nademanee, Auayporn ;

Forman, Stephen J. ;

Gopal, Ajay K. .

BLOOD, 2012, 119 (26) :6379-6381

[4] Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma [J].

Davis, R. Eric ;

Ngo, Vu N. ;

Lenz, Georg ;

Tolar, Pavel ;

Young, Ryan M. ;

Romesser, Paul B. ;

Kohlhammer, Holger ;

Lamy, Laurence ;

Zhao, Hong ;

Yang, Yandan ;

Xu, Weihong ;

Shaffer, Arthur L. ;

Wright, George ;

Xiao, Wenming ;

Powell, John ;

Jiang, Jian-Kang ;

Thomas, Craig J. ;

Rosenwald, Andreas ;

Ott, German ;

Muller-Hermelink, Hans Konrad ;

Gascoyne, Randy D. ;

Connors, Joseph M. ;

Johnson, Nathalie A. ;

Rimsza, Lisa M. ;

Campo, Elias ;

Jaffe, Elaine S. ;

Wilson, Wyndham H. ;

Delabie, Jan ;

Smeland, Erlend B. ;

Fisher, Richard I. ;

Braziel, Rita M. ;

Tubbs, Raymond R. ;

Cook, J. R. ;

Weisenburger, Dennis D. ;

Chan, Wing C. ;

Pierce, Susan K. ;

Staudt, Louis M. .

NATURE, 2010, 463 (7277) :88-U97

[5] Ibrutinib treatment ameliorates murine chronic graft-versus-host disease [J].

Dubovsky, Jason A. ;

Flynn, Ryan ;

Du, Jing ;

Harrington, Bonnie K. ;

Zhong, Yiming ;

Kaffenberger, Benjamin ;

Yang, Carrie ;

Towns, William H. ;

Lehman, Amy ;

Johnson, Amy J. ;

Muthusamy, Natarajan ;

Devine, Steven M. ;

Jaglowski, Samantha ;

Serody, Jonathan S. ;

Murphy, William J. ;

Munn, David H. ;

Luznik, Leo ;

Hill, Geoffrey R. ;

Wong, Henry K. ;

MacDonald, Kelli K. P. ;

Maillard, Ivan ;

Koreth, John ;

Elias, Laurence ;

Cutler, Corey ;

Soiffer, Robert J. ;

Antin, Joseph H. ;

Ritz, Jerome ;

Panoskaltsis-Mortari, Angela ;

Byrd, John C. ;

Blazar, Bruce R. .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (11) :4867-4876

[6] Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma [J].

Garciaz, Sylvain ;

Coso, Diane ;

Peyrade, Frederic ;

Fuerst, Sabine ;

Duran, Segolene ;

Chetaille, Bruno ;

Brenot-Rossi, Isabelle ;

Devillier, Raynier ;

Granata, Angela ;

Blaise, Didier ;

Bouabdallah, Reda .

HEMATOLOGICAL ONCOLOGY, 2014, 32 (04) :187-191

[7] B cell antigen receptor signaling: Roles in cell development and disease [J].

Gauld, SB ;

Dal Porto, JM ;

Cambier, JC .

SCIENCE, 2002, 296 (5573) :1641-1642

[8] Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma [J].

Illidge, Tim ;

Bouabdallah, Reda ;

Chen, Robert ;

Gopal, Ajay K. ;

Moskowitz, Craig H. ;

Ramchandren, Radhakrishnan ;

Shustov, Andrei R. ;

Tilly, Herve ;

Trippett, Tanya M. ;

Gibb, Adam ;

Grove, Laurie E. ;

Advani, Ranjana .

LEUKEMIA & LYMPHOMA, 2015, 56 (03) :703-710

[9]

Rule S., 2013, BLOOD, V122, P4397

[10]

Salles GA, 2013, BLOOD, V122

← 1 2 →